Catalyst Wire Dossier Catalyst Wire Dossier

KRN23

burosumab · Kyowa Kirin Co., Ltd.
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for KRN23, covering 2017-03-03 to 2024-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH [Phase 4]

See pricing